Mersana Therapeutics Inc (MRSN)
NASDAQ:MRSN
Holding MRSN?
Track your performance easily

Mersana Therapeutics (MRSN) Financial Statements

435 Followers

Mersana Therapeutics Financial Overview

Mersana Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.864; its P/E ratio is -2.97; Mersana Therapeutics is scheduled to report earnings on November 13, 2024, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 2.29M$ 9.24M$ 10.70M$ 7.70M$ 10.65M
Gross Profit$ 2.29M$ 9.24M$ 10.70M$ 7.70M$ 10.65M
EBIT$ -24.30M$ -18.30M$ -18.50M$ -40.64M$ -54.30M
EBITDA$ -22.78M$ -17.88M$ -18.05M$ -40.21M$ -52.56M
Net Income Common Stockholders$ -24.27M$ -19.31M$ -19.54M$ -41.66M$ -54.31M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 59.00M$ 75.19M$ 174.56M$ 186.28M$ 128.73M
Total Assets$ 179.13M$ 198.37M$ 226.06M$ 262.90M$ 311.00M
Total Debt$ 32.31M$ 33.08M$ 33.63M$ 34.34M$ 35.03M
Net Debt$ -26.69M$ -42.11M$ -140.93M$ -151.94M$ -93.70M
Total Liabilities$ 170.70M$ 170.39M$ 189.16M$ 210.71M$ 221.20M
Stockholders Equity$ 8.43M$ 27.95M$ 36.90M$ 52.20M$ 89.80M
Cash Flow-
Free Cash Flow$ -21.86M$ -32.79M$ -32.35M$ -46.55M$ -62.23M
Operating Cash Flow$ -21.86M$ -32.66M$ -31.96M$ -46.08M$ -61.83M
Investing Cash Flow$ 5.51M$ -72.55M$ 20.15M$ 103.78M$ -5.44M
Financing Cash Flow$ 153.00K$ 5.83M$ 92.00K$ -146.00K$ 73.18M
Currency in USD

Mersana Therapeutics Earnings and Revenue History

Mersana Therapeutics Debt to Assets

Mersana Therapeutics Cash Flow

Mersana Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis